Health

STAT+: Pharma’s trade group spent heavily on search ads to sway public opinion

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 06/11/2026, 08:21:25 UTC.

Briefings

A pharmaceutical industry lobbying group spent $59 million on search ads over seven years to shape public perception of prescription drug costs. The group, PhRMA, allocated $32 million to ads targeting insurance searches and $28 million to web pages criticizing pharmacy benefit managers. This activity surged around Medicare's 2023 drug price negotiations, with PhRMA generating 17.1 million paid visits using over 283,500 keywords between 2019 and 2025.

Key points

• PhRMA spent $32 million on ads linked to insurance and health plan searches.
• PhRMA spent $28 million directing traffic to web pages criticizing pharmacy benefit managers.

Context

The analysis models spending to understand how industry groups influence public views on prescription drug costs, specifically noting the surge around Medicare's 2023 drug price negotiations.

Limitations

Data covers a seven-year period (2019-2025) and is limited to search advertising metrics; specific outcomes of the ads are not reported.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 06/11/2026, 10:01:51 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeid2h7jw7jvr4p5wybo3p2jcoiuhctfgyv6juqji32zj6wypqo3vpm